• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[具有红细胞补体调节活性的糖基磷脂酰肌醇锚定蛋白]

[Glycosylphosphatidylinositol-anchored proteins with complement-regulatory activity on erythrocytes].

作者信息

Kawaguchi T, Nakakuma H

机构信息

Second Department of Internal Medicine, Kumamoto University School of Medicine.

出版信息

Nihon Rinsho. 1996 Sep;54(9):2370-5.

PMID:8890564
Abstract

Decay-accelerating factor (DAF) and CD59 are major complement regulators linked to plasma membrane via glycosylphosphatidylinositol anchor and inhibit C3 activation and the formation of membrane attack complex, respectively. These factors have been shown to protect human erythrocytes from the lytic action of autologous complement. Here we overview structure and function of these molecules, and discuss about their physiological roles in controlling the complement activation, ie, defining the susceptibility of erythrocytes to complement.

摘要

衰变加速因子(DAF)和CD59是通过糖基磷脂酰肌醇锚定连接到质膜的主要补体调节因子,分别抑制C3活化和膜攻击复合物的形成。这些因子已被证明可保护人类红细胞免受自身补体的溶解作用。在此,我们概述这些分子的结构和功能,并讨论它们在控制补体激活中的生理作用,即确定红细胞对补体的易感性。

相似文献

1
[Glycosylphosphatidylinositol-anchored proteins with complement-regulatory activity on erythrocytes].[具有红细胞补体调节活性的糖基磷脂酰肌醇锚定蛋白]
Nihon Rinsho. 1996 Sep;54(9):2370-5.
2
Glucose-induced loss of glycosyl-phosphatidylinositol-anchored membrane regulators of complement activation (CD59, CD55) by in vitro cultured human umbilical vein endothelial cells.体外培养的人脐静脉内皮细胞通过葡萄糖诱导导致补体激活的糖基磷脂酰肌醇锚定膜调节因子(CD59、CD55)丢失。
Diabetologia. 2000 Aug;43(8):1039-47. doi: 10.1007/s001250051487.
3
Crry, but not CD59 and DAF, is indispensable for murine erythrocyte protection in vivo from spontaneous complement attack.Crry,而非CD59和衰变加速因子(DAF),对于小鼠红细胞在体内免受自发补体攻击至关重要。
Blood. 2002 May 15;99(10):3707-16. doi: 10.1182/blood.v99.10.3707.
4
Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.检测衰变加速因子(DAF,CD55)和CD59减轻补体介导的异种红细胞损伤的能力。
Scand J Immunol. 1993 Jul;38(1):37-44. doi: 10.1111/j.1365-3083.1993.tb01691.x.
5
The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.马拉松跑步对红细胞上补体调节蛋白CD55(衰变加速因子)和CD59(膜攻击复合物抑制因子)表达的影响。
Eur J Appl Physiol. 2007 Jan;99(2):201-4. doi: 10.1007/s00421-006-0326-2. Epub 2006 Nov 7.
6
Protection of human nasal respiratory epithelium from complement-mediated lysis by cell-membrane regulators of complement activation.补体激活的细胞膜调节因子对人鼻呼吸上皮细胞的补体介导溶解的保护作用。
Am J Respir Cell Mol Biol. 1996 Dec;15(6):731-7. doi: 10.1165/ajrcmb.15.6.8969267.
7
Analysis of the effects of activation of the alternative pathway of complement on erythrocytes with an isolated deficiency of decay accelerating factor.对补体替代途径激活对衰变加速因子单独缺乏的红细胞的影响的分析。
J Immunol. 1992 Jan 15;148(2):498-502.
8
Impaired expression of erythrocyte glycosyl-phosphatidylinositol-anchored membrane CD59 in patients with psoriatic arthritis. Relation to terminal complement pathway activation.银屑病关节炎患者红细胞糖基磷脂酰肌醇锚定膜CD59表达受损。与末端补体途径激活的关系。
Clin Exp Rheumatol. 2003 Mar-Apr;21(2):225-8.
9
Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).人类癌症会不同程度地表达补体抑制蛋白CD46(膜辅因子蛋白)、CD55(衰变加速因子)和CD59(保护素)。
Am J Pathol. 1996 Jul;149(1):129-42.
10
Role of decay-accelerating factor in regulating complement activation on the erythrocyte surface as revealed by gene targeting.基因靶向揭示衰变加速因子在调节红细胞表面补体激活中的作用。
Proc Natl Acad Sci U S A. 1999 Jan 19;96(2):628-33. doi: 10.1073/pnas.96.2.628.